|
Market Closed -
Nasdaq
16:00:00 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 2.370 USD | -4.05% |
|
+4.87% | +45.40% |
| 10-06 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 09-20 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
Chart calendar Ovid Therapeutics Inc.
Upcoming events on Ovid Therapeutics Inc.
No events available
Past events on Ovid Therapeutics Inc.
| 2026-06-10 | Présentation aux Actionnaires / Analystes | 10:30 |
| 2026-06-10 | Annual General Meeting | 10:30 |
| 2026-04-14 | Information meeting | 09:30 |
| 2026-03-18 | Earnings presentation | 08:30 |
| 2025-12-11 | Extraordinary General Meeting | 09:00 |
| 2025-12-11 | Présentation aux Actionnaires / Analystes | 09:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,39 10,3 -96.19% | 0,57 0,66 -14% | 7,25 6,60 9.9% | 0,79 | 0,33 | 10,7 |
|
EBITDA Million USD | Released Forecast Spread | -57,7 -22,0 -161.68% | -60,2 -63,3 4.99% | 0,00 0,00 - | -70,8 | -86,7 | -130 |
|
EBIT Million USD | Released Forecast Spread | -59,3 -43,8 -35.36% | -61,9 -64,5 4.09% | -42,4 -42,3 -0.41% | -72,0 | -88,5 | -104 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,3 -39,9 -31.21% | -26,4 -34,5 23.33% | -17,4 -40,0 56.49% | -68,4 | -83,6 | -105 |
|
Net income Million USD | Released Forecast Spread | -52,3 -39,2 -33.48% | -26,4 -33,5 21.2% | -17,4 -40,0 56.49% | -66,3 | -83,1 | -96,9 |
|
EPS USD | Released Forecast Spread | -0,74 -0,56 -33.25% | -0,37 -0,47 21.28% | -0,23 -0,47 51.44% | -0,36 | -0,39 | -0,40 |
| Announcement Date | 08/03/24 | 11/03/25 | 18/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,08 0,19 -59.47% | 0,13 0,03 420% | 6,27 0,09 6631.78% | 0,13 0,17 -22.53% | 0,72 0,06 1046.96% | 0,00 0,05 - | 0,73 0,00 - | 0,03 | 0,08 | 0,02 | 0,02 | 0,02 | 0,02 |
|
EBITDA Million USD | Released Forecast Spread | -10,3 -13,3 22.8% | -17,4 | -17,2 | -22,0 | -22,3 | -21,4 | -21,1 | ||||||
|
EBIT Million USD | Released Forecast Spread | -10,7 -12,8 16.09% | -12,6 -10,4 -20.98% | -5,07 -12,1 57.97% | -12,5 -11,0 -13.86% | -12,3 -12,3 0.39% | -17,8 -13,7 -30.46% | -15,7 -19,4 19.18% | -18,3 | -20,0 | -21,4 | -22,5 | -23,6 | -25,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,28 -11,7 20.86% | -10,2 -9,70 -5.54% | -4,68 -11,1 57.84% | -12,2 -10,8 -12.4% | 9,66 -12,2 179.38% | -17,0 -13,4 -26.97% | -15,0 -19,1 21.25% | -17,3 | -18,7 | -19,9 | -21,1 | -22,3 | -23,8 |
|
Net income Million USD | Released Forecast Spread | -9,28 -11,6 19.77% | -10,2 -9,80 -4.45% | -4,68 -11,1 57.81% | -12,2 -10,8 -13.06% | 9,66 -12,2 179.38% | -17,0 -13,5 -25.38% | -15,0 -18,8 20.04% | -16,8 | -17,2 | -19,6 | -21,0 | -22,2 | -23,9 |
|
EPS USD | Released Forecast Spread | -0,13 -0,16 20.18% | -0,14 -0,14 -1.03% | -0,06 -0,16 62.16% | -0,17 -0,15 -13.33% | 0,06 -0,11 155.1% | -0,12 -0,12 -1.05% | -0,08 -0,12 30.43% | -0,08 | -0,09 | -0,09 | -0,09 | -0,10 | -0,11 |
| Announcement Date | 11/03/25 | 13/05/25 | 13/08/25 | 12/11/25 | 18/03/26 | 12/05/26 | 13/08/26 | - | - | - | - | - | - |
| Today |  | Information meeting | 08:00 |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Information meeting | 07:00 |
| 2026-10-26 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-27 | | Earnings release - Q3 2026 | |
| 2026-10-27 | | Information meeting | 08:00 |
| 2026-10-27 | | Earnings release - Q3 2026 |
Past sector events for Ovid Therapeutics Inc.
| Today | | Extraordinary General Meeting | 02:00 |
| 2026-10-22 | | Earnings release - Q3 2026 | |
| 2026-10-22 | | Earnings presentation | 08:30 |
| 2026-10-21 | | Information meeting | 09:00 |
| 2026-10-14 | | Information meeting | 14:30 |
| 2026-10-14 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-14 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-14 | | Information meeting | 08:00 |
| 2026-10-13 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
- Calendar Ovid Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
